Gorgani Fateme, Sharafkhah Maryam, Masoudi Sahar, Poustchi Hossein, Delavari Alireza, Sadjadi Alireza, Roshandel Gholamreza, Khoshnia Masoud, Eslami Layli, Rezaei Negar, Sepanlou Sadaf G
Digestive Disease Research Center (DDRC), Digestive Disease Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
Liver and Pancreatobiliary Diseases Research Center, Digestive Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
Int J Cardiol Cardiovasc Risk Prev. 2024 May 8;21:200279. doi: 10.1016/j.ijcrp.2024.200279. eCollection 2024 Jun.
Cardiovascular diseases (CVDs) are the leading causes of global mortality and disability. Several studies demonstrated that metabolic risk factors increase cardiovascular mortality. The aim of this study is to examine CVDs deaths and population attributable fractions (PAFs) of their metabolic risk factors in Iran.
This is a study on 8621 participants aged 45-75 years and older, recruited in the repeated measurement phase of the Golestan cohort study (GCS) in northeast of Iran. The Cox proportional hazards model was used to determine the adjusted hazard ratios (HRs). PAFs were calculated to enumerate CVDs mortality avoidable in the population if metabolic risk factors were eliminated.
The mortality of CVDs was attributable to metabolic factors, including high waist circumference (PAF, 28 %, [95 % CI: 16%-38 %]), high fasting blood sugar (FBS) (20 %, [15%-24 %]), overweight and obesity (19 %, [8%-28 %]), high blood pressure (16 %, [11%-21 %]), high low-density lipoprotein cholesterol (LDL-C) (8 %, [1%-15 %]), and high triglyceride (TG) (7 %, [3%-11 %]). Collectively, these metabolic risk factors accounted for 50 % of CVDs deaths. Females (67 %, [50%-78 %]) had a higher joint PAF of metabolic risk factors compared to males (43 %, [27%-55 %]).
The pattern of CVDs mortality attributable to metabolic risk factors in this study is not the same as similar studies in other parts of the world and previous studies in Iran. It is imperative that CVDs risk factors be specifically evaluated and addressed in various populations due to variety in geographical and temporal patterns in contribution of metabolic risk factors to CVD mortality.
心血管疾病(CVDs)是全球死亡和残疾的主要原因。多项研究表明,代谢危险因素会增加心血管疾病死亡率。本研究旨在调查伊朗心血管疾病死亡情况及其代谢危险因素的人群归因分数(PAFs)。
本研究纳入了8621名年龄在45 - 75岁及以上的参与者,他们来自伊朗东北部戈勒斯坦队列研究(GCS)的重复测量阶段。采用Cox比例风险模型确定调整后的风险比(HRs)。计算PAFs以确定如果消除代谢危险因素,人群中可避免的心血管疾病死亡率。
心血管疾病死亡率归因于代谢因素,包括高腰围(PAF,28%,[95%CI:16% - 38%])、高空腹血糖(FBS)(20%,[15% - 24%])、超重和肥胖(19%,[8% - 28%])、高血压(16%,[11% - 21%])、高低密度脂蛋白胆固醇(LDL - C)(8%,[1% - 15%])和高甘油三酯(TG)(7%,[3% - 11%])。总体而言,这些代谢危险因素占心血管疾病死亡人数的50%。女性(67%,[50% - 78%])的代谢危险因素联合PAF高于男性(43%,[27% - 55%])。
本研究中代谢危险因素导致的心血管疾病死亡模式与世界其他地区类似研究以及伊朗先前的研究不同。由于代谢危险因素对心血管疾病死亡率的贡献在地理和时间模式上存在差异,因此必须在不同人群中对心血管疾病危险因素进行具体评估和处理。